OBJECTIVE: Although a number of studies have reported elevated levels of markers of myocardial necrosis among critically ill patients, the association between these markers and outcome remains poorly studied in patients with lung injury. We investigated the association of elevated troponin and creatine phosphokinase isoenzyme levels with mortality and organ failure in subjects with acute respiratory distress syndrome. DESIGN: Retrospective study. SETTING: Tertiary academic medical center. PATIENTS: A total of 305 subjects with acute respiratory distress syndrome enrolled in a prospective intensive care unit cohort. INTERVENTION: None. MEASUREMENTS AND MAIN RESULTS: Cardiac biomarker data were available on 248 of 305 patients with acute respiratory distress syndrome (81%), of which 89 patients had at least one elevated cardiac marker level (35%). The presence of an elevated cardiac marker was associated with significantly higher mortality (p = .01) and was an independent predictor of mortality (p = .02) among patients with lower severity of illness (Acute Physiology and Chronic Health Evaluation III, <79). Patients with at least one elevated cardiac marker also had significantly more organ system derangement, including noncardiovascular organ system failures (p = .02). CONCLUSIONS: Patients with acute respiratory distress syndrome have a high prevalence of elevated cardiac markers. The presence of elevated cardiac markers is independently associated with increased 60-day mortality and increased organ failure. This association is most pronounced among patients with lower severity of illness. These results indicate that occult myocardial injury may be an important factor in acute respiratory distress syndrome morbidity and mortality. Further study of the relevant causal relationships and mechanisms is warranted.
OBJECTIVE: Although a number of studies have reported elevated levels of markers of myocardial necrosis among critically ill patients, the association between these markers and outcome remains poorly studied in patients with lung injury. We investigated the association of elevated troponin and creatine phosphokinase isoenzyme levels with mortality and organ failure in subjects with acute respiratory distress syndrome. DESIGN: Retrospective study. SETTING: Tertiary academic medical center. PATIENTS: A total of 305 subjects with acute respiratory distress syndrome enrolled in a prospective intensive care unit cohort. INTERVENTION: None. MEASUREMENTS AND MAIN RESULTS: Cardiac biomarker data were available on 248 of 305 patients with acute respiratory distress syndrome (81%), of which 89 patients had at least one elevated cardiac marker level (35%). The presence of an elevated cardiac marker was associated with significantly higher mortality (p = .01) and was an independent predictor of mortality (p = .02) among patients with lower severity of illness (Acute Physiology and Chronic Health Evaluation III, <79). Patients with at least one elevated cardiac marker also had significantly more organ system derangement, including noncardiovascular organ system failures (p = .02). CONCLUSIONS:Patients with acute respiratory distress syndrome have a high prevalence of elevated cardiac markers. The presence of elevated cardiac markers is independently associated with increased 60-day mortality and increased organ failure. This association is most pronounced among patients with lower severity of illness. These results indicate that occult myocardial injury may be an important factor in acute respiratory distress syndrome morbidity and mortality. Further study of the relevant causal relationships and mechanisms is warranted.
Authors: Thomas S Metkus; Eliseo Guallar; Lori Sokoll; David Morrow; Gordon Tomaselli; Roy Brower; Steven Schulman; Frederick K Korley Journal: Crit Care Med Date: 2017-10 Impact factor: 7.598
Authors: Carolyn S Calfee; Lorraine B Ware; David V Glidden; Mark D Eisner; Polly E Parsons; B Taylor Thompson; Michael A Matthay Journal: Crit Care Med Date: 2011-04 Impact factor: 7.598
Authors: Thomas S Metkus; Eliseo Guallar; Lori Sokoll; David A Morrow; Gordon Tomaselli; Roy Brower; Bo Soo Kim; Steven Schulman; Frederick K Korley Journal: J Crit Care Date: 2018-08-16 Impact factor: 3.425
Authors: Jehan W Alladina; Sean D Levy; Kathryn A Hibbert; James L Januzzi; R Scott Harris; Michael A Matthay; B Taylor Thompson; Ednan K Bajwa Journal: Crit Care Med Date: 2016-09 Impact factor: 7.598
Authors: Marilyn Hravnak; J Michael Frangiskakis; Elizabeth A Crago; Yuefang Chang; Masaki Tanabe; John Gorcsan; Michael B Horowitz Journal: Stroke Date: 2009-08-27 Impact factor: 7.914
Authors: Ednan K Bajwa; James L Januzzi; Michelle N Gong; B Taylor Thompson; David C Christiani Journal: Crit Care Med Date: 2008-08 Impact factor: 7.598
Authors: Ednan K Bajwa; Jessica A Volk; David C Christiani; R Scott Harris; Michael A Matthay; B Taylor Thompson; James L Januzzi Journal: Crit Care Med Date: 2013-11 Impact factor: 7.598
Authors: Matthew B Rivara; Ednan K Bajwa; James L Januzzi; Michelle N Gong; B Taylor Thompson; David C Christiani Journal: PLoS One Date: 2012-07-12 Impact factor: 3.240